Outcomes Favorable for HIV+ Kidney Transplant Recipients

This article originally appeared here.
Share this content:
Outcomes Favorable for HIV+ Kidney Transplant Recipients
Outcomes Favorable for HIV+ Kidney Transplant Recipients

FRIDAY, March 20, 2015 (HealthDay News) -- Kidney transplant patients with HIV have similar survival rates as those without HIV, a new study finds. The findings were published online March 19 in the Journal of the American Society of Nephrology.

The study included 510 HIV-positive adults who had kidney transplants in the United States between 2002 and 2011. Overall, these patients had similar five- and 10-year survival rates as kidney transplant patients without HIV. However, transplant recipients who had both HIV and hepatitis C had lower survival rates than those without HIV, the researchers found. About 25 percent of kidney transplant patients with HIV also have hepatitis C.

The findings suggest that excellent results are possible among HIV-positive kidney transplant recipients. However, doctors should be cautious when considering transplants involving patients with both HIV and hepatitis C, Jayme Locke, M.D., M.P.H., from the University of Alabama at Birmingham, and colleagues concluded.

The study provides "a national perspective on the status of HIV transplantation which supports the expanded use of kidney transplantation in this group," Alissa Wright, M.D., and John Gill, M.D., from the University of British Columbia in Vancouver, Canada, write in an accompanying journal editorial.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »